Development of a Method for the Chiral Separation of D/L‑Amphetamine

Importance of the Topic

Amphetamine exists as two chiral enantiomers, with the D-form exhibiting greater pharmacological activity.
Accurate enantiomeric separation and quantification are critical in forensic toxicology to distinguish legitimate therapeutic use from illicit consumption.

Objectives and Study Overview

This study describes the development of a rapid supercritical fluid chromatography–mass spectrometry (SFC/MS) method for enantioselective analysis of D- and L-amphetamine.
The work involved screening chiral stationary phases, optimizing mobile phase composition and instrument parameters, and applying the finalized method to an authentic whole blood sample.

Applied Methodology

Sample Preparation:

• Protein precipitation of whole blood with acetonitrile.
• Dilution series (1:10, 1:100, 1:1 000) in ethanol containing 0.1 % aqueous ammonia.

Chromatographic Conditions:

• Stationary Phase: CHIRALPAK AD-H column (150 × 4.6 mm, 5 μm).
• Mobile Phase: CO₂ with 10 % ethanol + 0.1 % NH₃ (aqueous).
• Flow Rate: 4 mL/min; Column Temperature: 20 °C; Back Pressure: 200 bar.
• Run Time: 3 minutes; Injection Volume: 5 μL.

Mass Spectrometry:

• Make-up Solvent: Methanol/water (95/5) + 0.2 % formic acid at 0.4 mL/min.
• Ionization: ESI positive with Agilent Jet Stream and iFunnel.
• MRM Transitions: 136.1→119.1 and 136.1→91.1; optimized fragmentor and collision energies.

Instrumentation Used

• Agilent 1260 Infinity II SFC System (Control Module, Binary Pump, Multisampler, DAD, Multicolumn Thermostat, Isocratic Pump, SFC/MS Splitter Kit).
• Agilent 6495 Triple Quadrupole Mass Spectrometer with Jet Stream and iFunnel technology.

Main Results and Discussion

Column and Modifier Screening led to the selection of ethanol with 0.1 % ammonia as the optimum modifier, providing baseline enantiomer separation.
Increasing flow rate from 3 to 4 mL/min and shortening the column length from 250 mm to 150 mm reduced elution times of both enantiomers to under 2.1 minutes.
Optimal resolution was achieved at 20 °C. Back pressure of 200 bar maximized MS sensitivity, and make-up solvent flow had minimal impact on signal.
Calibration over 0.1–100 ng/mL yielded excellent linearity (R² > 0.9996). Limits of quantification were 0.1 ng/mL (S/N = 10) and detection at 0.04 ng/mL (S/N = 3).
The method successfully quantified D- and L-amphetamine in an authentic whole blood extract across multiple dilutions, demonstrating forensic applicability.

Benefits and Practical Applications

This SFC/MS workflow offers rapid chiral separation, high sensitivity, and short cycle times, enabling high-throughput forensic screening.
It differentiates enantiomers to establish whether amphetamine originates from pharmaceutical preparations or illicit sources, supporting legal and clinical investigations.

Future Trends and Opportunities

Integration with high-resolution MS and automation of sample preparation could expand this approach to broader chiral drug panels.
Online coupling of SFC with MS and further miniaturization will enhance throughput and applicability in toxicology and pharmaceutical quality control.

Conclusion

A robust, validated SFC/MS method for enantioselective separation and quantification of D/L-amphetamine in whole blood has been established.
The protocol achieves baseline resolution, rapid run times, and low pg-level detection limits, meeting the demands of forensic laboratories.

References

• Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present – a pharmacological and clinical perspective. Journal of Psychopharmacology. 2013;27(6):479–496.
• Kde Mariotti C, Amendola J, Pascali JP. Simultaneous analysis of amphetamine-type stimulants in plasma by solid-phase microextraction and gas chromatography-mass spectrometry. Journal of Analytical Toxicology. 2014;38(7):432–437.
• Agilent Technologies Inc. Use of the SFC-MS Splitter Kit G4309-68715. Technical Note G4309-90130. 2015.